Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration

This cohort study compares amputation and mortality rates among patients treated in the Veterans Health Administration for diabetic foot osteomyelitis with and without rifampin.

[1]  W. Newsholme,et al.  Retrospective analysis of diabetic foot osteomyelitis management and outcome at a tertiary care hospital in the UK , 2019, PloS one.

[2]  A. Briggs,et al.  Oral versus Intravenous Antibiotics for Bone and Joint Infection , 2019, The New England journal of medicine.

[3]  D. Wukich,et al.  Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death , 2018, Foot & ankle specialist.

[4]  F. Vandenesch,et al.  Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus , 2015, Antimicrobial Agents and Chemotherapy.

[5]  G. Donelli.  Biofilm-based Healthcare-associated Infections , 2015, Advances in Experimental Medicine and Biology.

[6]  J. Lázaro-Martínez,et al.  Antibiotics Versus Conservative Surgery for Treating Diabetic Foot Osteomyelitis: A Randomized Comparative Trial , 2014, Diabetes Care.

[7]  R. Écochard,et al.  Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.

[8]  Richard D. Smith,et al.  Activated ClpP kills persisters and eradicates a chronic biofilm infection , 2013, Nature.

[9]  Benjamin A Lipsky,et al.  The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds , 2013, Scandinavian journal of infectious diseases.

[10]  D. Lebeaux,et al.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections , 2013, Pathogens.

[11]  É. Senneville,et al.  Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn , 2013, Expert opinion on pharmacotherapy.

[12]  David G Armstrong,et al.  2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. , 2013, Journal of the American Podiatric Medical Association.

[13]  Benjamin A Lipsky,et al.  Systemic antibiotic therapy for chronic osteomyelitis in adults. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  David G. Armstrong,et al.  Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa , 2012 .

[15]  Donald R. Miller,et al.  Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study , 2010, BMC health services research.

[16]  Y. Yazdanpanah,et al.  Outcome of Diabetic Foot Osteomyelitis Treated Nonsurgically , 2008, Diabetes Care.

[17]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[18]  D. Palmer,et al.  Chronic Osteomyelitis Caused by Staphylococcus aureus: Controlled Clinical Trial of Nafcillin Therapy and Nafcillin-Rifampin Therapy , 1986, Southern medical journal.

[19]  J. Thys,et al.  Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections , 1985, Antimicrobial Agents and Chemotherapy.

[20]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.